TrialArthritis research & therapy2010

B cell depletion in diffuse progressive systemic sclerosis: safety, skin score modification and IL-6 modulation in an up to thirty-six months follow-up open-label trial.

Silvia Bosello et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.